Can Angiogenesis be a Target of Treatment for Ribavirin Associated Hemolytic Anemia?

---

Atıf İçin Kopyala

Yonem O., Arslan S. , Sokmensuer C. , Salmanzade S.

HEPATO-GASTROENTEROLOGY, cilt.57, ss.562-566, 2010 (SCI İndekslerine Giren Dergi)

• Cilt numarası: 57
• Basım Tarihi: 2010
• Dergi Adı: HEPATO-GASTROENTEROLOGY
• Sayfa Sayıları: ss.562-566

Özet

Background/Aims: Recently ribavirin has been found to inhibit angiogenesis and a number of angiogenesis inhibitors such as sunitinib and sorafenib have been found to cause acute hemolysis. We aimed to investigate whether there is a relation between hemoglobin, haptoglobin and angiogenesis soluble markers which are modifiable and can help in developing strategies against anemia.